Compare CMP & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMP | LMRI |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2003 | 2025 |
| Metric | CMP | LMRI |
|---|---|---|
| Price | $25.76 | $11.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $21.50 | $20.75 |
| AVG Volume (30 Days) | ★ 465.4K | 438.5K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.59 | 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | $1.29 | $5.61 |
| P/E Ratio | ★ $44.69 | $240.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.40 | $6.45 |
| 52 Week High | $34.50 | $19.45 |
| Indicator | CMP | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 62.31 |
| Support Level | $22.98 | $10.09 |
| Resistance Level | $31.44 | $12.93 |
| Average True Range (ATR) | 1.38 | 0.69 |
| MACD | -0.25 | 0.07 |
| Stochastic Oscillator | 43.33 | 68.25 |
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.